165 companies
Zevra Therapeutics
Market Cap: US$595.3m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$10.07
7D
-0.1%
1Y
25.9%
Madrigal Pharmaceuticals
Market Cap: US$11.8b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$513.72
7D
0.3%
1Y
62.8%
Infinity Natural Resources
Market Cap: US$1.0b
Engages in the acquisition, exploration, and development of properties to produce crude oil, natural gas, and natural gas liquids in the United States.
INR
US$16.19
7D
1.3%
1Y
-0.3%
Travere Therapeutics
Market Cap: US$4.1b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$44.12
7D
8.9%
1Y
108.6%
AVITA Medical
Market Cap: US$136.6m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$4.44
7D
-0.4%
1Y
-51.9%
Syndax Pharmaceuticals
Market Cap: US$1.7b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$19.11
7D
-10.7%
1Y
39.2%
T1 Energy
Market Cap: US$1.4b
Provides energy solutions for solar modules and cells in the United States, Norway and internationally.
TE
US$5.15
7D
-2.6%
1Y
287.2%
Aura Minerals
Market Cap: US$6.9b
A gold and copper production company, focuses on the development and operation of gold and base metal projects in the Americas.
AUGO
US$82.16
7D
-9.0%
1Y
313.3%
AppLovin
Market Cap: US$154.7b
Provides end-to-end artificial intelligence-powered advertising solutions for businesses in the United States and internationally.
APP
US$460.00
7D
2.6%
1Y
49.6%
AnaptysBio
Market Cap: US$1.9b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$66.76
7D
13.4%
1Y
215.1%
Ardelyx
Market Cap: US$1.7b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.88
7D
15.6%
1Y
66.6%
WaterBridge Infrastructure
Market Cap: US$3.7b
WaterBridge Infrastructure LLC, water infrastructure company, provides water management solutions through integrated pipeline and water handling networks in the United States.
WBI
US$29.73
7D
4.4%
1Y
n/a
Oracle
Market Cap: US$494.2b
Offers products and services that address enterprise information technology environments worldwide.
ORCL
US$171.83
7D
-0.8%
1Y
14.0%
AGI
Market Cap: US$1.1b
Provides technology-based specialized financial services in Brazil.
AGBK
US$6.82
7D
-10.0%
1Y
n/a
Alignment Healthcare
Market Cap: US$4.2b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$20.26
7D
-4.1%
1Y
30.5%
FTAI Aviation
Market Cap: US$24.6b
Owns, acquires, and sells aviation equipment for the transportation of goods and people worldwide.
FTAI
US$239.95
7D
3.0%
1Y
166.8%
Caledonia Mining
Market Cap: US$436.9m
Primarily operates a gold mine in Jersey.
CMCL
US$22.62
7D
-10.5%
1Y
81.4%
Compass
Market Cap: US$5.5b
Provides an end-to-end technology platform for residential real estate in the United States.
COMP
US$7.39
7D
-5.9%
1Y
-7.0%
Pelthos Therapeutics
Market Cap: US$83.9m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$25.00
7D
8.4%
1Y
98.4%
UroGen Pharma
Market Cap: US$1.1b
A biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$23.00
7D
-4.6%
1Y
99.8%
Luckin Coffee
Market Cap: US$11.4b
Offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.
LKNC.Y
US$35.24
7D
11.9%
1Y
2.7%
CVB Financial
Market Cap: US$2.8b
Operates as bank holding company for Citizens Business Bank, National Association, a state-chartered bank that provides banking and financial services to small to mid-sized businesses and individuals.
CVBF
US$20.45
7D
1.9%
1Y
7.2%
Abeona Therapeutics
Market Cap: US$308.9m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.43
7D
0.7%
1Y
-17.2%
SM Energy
Market Cap: US$7.3b
An independent energy company, engages in the acquisition, exploration, development, and production of oil, gas, and natural gas liquids in the United States.
SM
US$30.47
7D
5.9%
1Y
33.5%
Aldeyra Therapeutics
Market Cap: US$95.7m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
ALDX
US$1.59
7D
2.6%
1Y
-43.4%
Capricor Therapeutics
Market Cap: US$1.8b
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$30.91
7D
-12.4%
1Y
160.6%
Pagaya Technologies
Market Cap: US$1.2b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services, their customers, and institutional or sophisticated investors in the United States, Israel, and the Cayman Islands.
PGY
US$14.24
7D
4.8%
1Y
20.3%
Nutanix
Market Cap: US$11.3b
Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.
NTNX
US$42.60
7D
5.0%
1Y
-41.3%
FirstSun Capital Bancorp
Market Cap: US$1.7b
Operates as the bank holding company for Sunflower Bank, National Association that provides commercial and consumer banking and financial services to small and medium-sized companies in the United States.
FSUN
US$35.93
7D
-6.0%
1Y
0.3%
Simmons First National
Market Cap: US$3.1b
Operates as the bank holding company for Simmons Bank that provides banking and other financial products and services to individuals and businesses.
SFNC
US$21.23
7D
1.0%
1Y
10.3%
CG Oncology
Market Cap: US$5.8b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$66.27
7D
-3.5%
1Y
128.1%
Arcutis Biotherapeutics
Market Cap: US$2.9b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$23.35
7D
0.4%
1Y
53.2%
Bitgo Holdings
Market Cap: US$1.2b
Operates as a digital asset infrastructure company in the United States and internationally.
BTGO
US$10.43
7D
-2.4%
1Y
n/a
Daqo New Energy
Market Cap: US$1.3b
Manufactures and sells polysilicon to photovoltaic product manufacturers in the People’s Republic of China.
DQ
US$19.14
7D
-16.7%
1Y
48.5%
Gossamer Bio
Market Cap: US$86.8m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.
GOSS
US$0.37
7D
2.0%
1Y
-68.7%
Intapp
Market Cap: US$1.9b
Through its subsidiary, Integration Appliance, Inc., provides AI-powered solutions in the United States, the United Kingdom, and internationally.
INTA
US$23.50
7D
5.6%
1Y
-59.6%